Colorectal cancer is a type of cancer that affects the colon and rectum. It is the third most common type of cancer in the world and is the second leading cause of cancer-related deaths in the United States. Treatment for colorectal cancer typically involves surgery, chemotherapy, and radiation therapy. In recent years, targeted therapies and immunotherapies have been developed to treat colorectal cancer. The oncology market for colorectal cancer is highly competitive, with a number of companies offering treatments and therapies. These include pharmaceutical companies such as Merck, Bristol-Myers Squibb, and Roche, as well as biotechnology companies such as ImmunoGen, Exelixis, and Incyte. Additionally, medical device companies such as Medtronic and Boston Scientific are involved in the development of treatments for colorectal cancer. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
